Nasal spray treating dry eye disease
A new treatment option may increase basal tear production in patients.
Trending now: RSC sees 32% YTD rise in LVC procedure volume over 2020
Renewed consumer interest in and demand for LASIK, SMILE, and other procedures are among the key drivers for 2021 performance.
Ocular surface tumors: Rare but deadly
Investigators find the prevalence of ocular surface tumors is greater in the North Central region of the United States.
MellingMedical to deliver CorneaGen tissue to federal health facilities
According to the companies, the agreement will open a channel between federal health facilities and CorneaGen's laboratories.
Aramis Biosciences announces FDA clearance of IND application for A197
According to the company, A197 is a novel, first-in-class, topical immunomodulatory agent which will move into Phase II clinical trials in dry eye patients.
MMC increases corneal haze after CXL
The application of mitomycin C after corneal cross-linking does not prevent development of corneal haze after the procedure, but it does contribute to development of more corneal haze.
High incidence of severe infectious keratitis in South India related to COVID-19
Delayed presentations and acute shortage of donor corneal tissues for emergency keratoplasty are among reasons given for adverse outcome.
Topical tacrolimus effective for vernal/atopic keratoconjunctivitis
With every 10-year increase in patient age, the risk of the patients needing concomitant administration of steroid eye drops decreased by half, according to investigators.
Investigators reimage immunity in the eye
A team of researchers from Thomas Jefferson University have found that immune cells could be doing much more than first thought in protecting our eyes.
Similar pterygium outcomes regardless of surgeons’ level of expertise
Analysis finds acceptable outcomes can be expected when pterygium surgery is performed by a supervised ophthalmology resident.
Cell therapy emerges as treatment option for corneal endothelial disease
New cell therapy drug makes treatment of corneal endothelial disease more accessible.
Prevent Blindness declares 2022 the “Year of Children’s Vision”
According to the organization, the goal is to highlight and address the diverse and critical vision and eye health needs of children and to improve outcomes through advocacy, public health, education, and awareness.
Survey gauges corneal surgeons’ attitudes regarding keratoplasty and vaccines
Although graft rejection has not been associated with vaccinations, concern remains.
DED results in imbalance of neuropeptides, neurotrophins in the cornea and trigeminal ganglion
Impairment of corneal sensory innervation causes reduction of both protective reflexes and trophic neuromodulators that are essential for the vitality, metabolism, and wound healing of the ocular surface.
Rethinking dry eye disease with acute steroid treatment
According to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation
I-MED Pharma USA gains distribution rights for ESW Vision’s dry eye devices
I-MED Pharma Inc., a Canadian-based firm, announced this week the expansion of its strategic partnership with ESW Vision in France to be their exclusive distributor in the United States.
TearLab names Adam Szaronos president and CEO, and Jim Mazzo executive chairman of the Board
TearLab Corp. announced that Adam Szaronos has been appointed president and CEO by the company's Board of Directors, effective immediately.
Dry eye severity, treatment varies among ethnic minority patients
Investigators are hopeful that future research can focus on public health concerns of dry eye disease.
AcuFocus receives Approvable Letter from FDA for small aperture IOL
The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022.
Ocular Therapeutix announces topline results for phase 2 clinical trial of OTX-DED for short-term treatment of dry eye disease
Study shows statistically significant improvement for primary endpoint of bulbar conjunctival hyperemia for OTX-DED 0.2 mg and 0.3 mg formulations compared with vehicle hydrogel insert.
Investigators use gene therapy treatment of Fuchs in animal models
Successful treatment options can offer hope for patients with inherited disease.
Strategies for targeting corneal neovascularization
Approaches include anti-vascular endothelial growth factor agents, fine needle diathermy, and corneal collagen crosslinking.
Artificial DMEK could help tackle endothelial donor tissue shortage
New acrylic implant provides option for patients with endothelial dysfunction.
Mitomycin C increases corneal haze after corneal crosslinking
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Corneal neurotization is effective for restoring sensory innervation
Procedure transfers intact donor nerve fibers to the cornea.
Landmark treatment: Cell therapy advances options for corneal endothelial disease
Results from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
What is happening with LipiFlow reimbursement?
Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.
Assessing the severity of Fuchs’ endothelial corneal dystrophy by using Scheimpflug tomography
Investigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.
Corneal mechanical sensitivity in individuals with chronic pain
A cross sectional study investigated how chronic pain conditions outside of the eye impact corneal sensitivity.
Researchers pioneer technology that leads successful clinical trial to treat dry eye disease
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
2 Clarke Drive Cranbury, NJ 08512